Back to results
US 2024/0226265 A9Published application
Lassa virus vaccine and uses thereof
AssigneeInovio Pharmaceuticals, Inc.
InventorsKate Broderick, Kathleen A. Cashman, Jean D. Boyer, Scott M. White
Life of this patent
Estimating the term…
Abstract
Described are methods of inducing a protective immune response against Lassa virus comprising administering a prophylactically effective amount of a nucleic acid molecule encoding a Lassa virus glycoprotein precursor (LASV GPC) to a subject in need thereof.
Claims18
A method of inducing a protective immune response against Lassa virus in a subject in need thereof, said method comprising administering a prophylactically effective amount of a nucleic acid molecule encoding the amino acid sequence of SEQ ID NO:
- 1 to the subject.
Dependencies are inferred from the claim text.